It's more than a result.
It's a person.

We're Driven To Know.

genetics-icon
Genetics

Innovative solutions that empower researchers, from ALS to fragile X syndrome.

Learn more about our Genetics portfolio
oncology-icon
Oncology

Solving complex molecular challenges, from leukemia to solid tumors.

Learn more about our Oncology portfolio
cdx-icon
Custom & Companion Diagnostics

One partner from clinical concept to product commercialization.

Learn more about partnering with us.
Spotlight

Asuragen Expands Oncology Portfolio with CE Marking and Launch of QuantideX® NGS DNA Hotspot 21 Kit

Asuragen Expands Oncology Portfolio with CE Marking and Launch of QuantideX® NGS DNA Hotspot 21 Kit, a targeted, next-generation sequencing panel for the detection of clinically relevant variants across a multitude of tumor types, including non-small cell lung cancer, colorectal cancer, and melanoma.

Read More
Spotlight

Asuragen Announces the Launch of AmplideX® PCR/CE SMN1 Kit

The AmplideX® PCR/CE SMN1 kit allows laboratories to quickly and easily determine SMN1 exon 7 copy number.

Learn more
Spotlight

Asuragen Expands Genetic Portfolio with Launch of AmplideX® PCR/CE DMPK Kit

The launch of the AmplideX® PCR/CE DMPK Kit represents an extension of Asuragen’s portfolio of easy-to-use testing kits for complex and challenging genetic targets.

Read more

The Latest from Asuragen

New Horizons for AmplideX® Technology: Portfolio Expansions to New High Complexity Targets & Beyond
Back To
Top

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close